KEY PRODUCTS
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1Cohance Lifesciences
01 1ARIPIPRAZOLE USP
01 1India
01 1Active
01 1Complete
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2017-11-16
Pay. Date : 2017-10-18
DMF Number : 30120
Submission : 2015-12-14
Status : Active
Type : II
20
Cohance Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
One of their notable products is ARIPIPRAZOLE USP, with a corresponding US DMF Number 30120.
Remarkably, this DMF maintains an Active status since its submission on December 14, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 16, 2017, and payment made on October 18, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
